Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy

This study has been terminated.
(Adverse Events)
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
University of Southern California
ClinicalTrials.gov Identifier:
NCT01238965
First received: November 3, 2010
Last updated: May 26, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2015
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)